ARS Pharmaceuticals, Inc.

SPRY·NASDAQ·$8.17Share Price as of 11/2·$811MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/26 10-QQ1 ended 03/31/2605/15/26 10-KFY 202503/09/26 10-QQ3 ended 09/30/2511/10/25 10-QQ2 ended 06/30/2508/13/25

Disclosures

8-KCurrent report08/13/26 8-KCurrent report07/17/26 8-KCurrent report07/07/26 8-KCurrent report06/25/26 8-KCurrent report05/15/26

Prospectuses and Registrations

S-8Registration of securities for employees03/09/26 S-8Registration of securities for employees03/20/25 S-3ASRAutomatic shelf registration01/31/25 S-8Registration of securities for employees03/21/24 S-3Shelf registration04/20/23

Proxies

DEF 14ADefinitive proxy04/29/26 DEFA14AAdditional proxy materials04/29/26 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25 DEF 14ADefinitive proxy04/26/24

Ownership

144Proposed sale of securities10/30/26 144Proposed sale of securities10/19/26 Form 4Insider transaction10/05/26 144Proposed sale of securities10/01/26 144Proposed sale of securities09/30/26

Other

ARSAnnual report to shareholders04/29/26 ARSAnnual report to shareholders04/29/25 UPLOADLetter from the SEC11/25/24 CORRESPCorrespondence with the SEC11/18/24 UPLOADLetter from the SEC11/07/24